Yield10 Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Yield10 Bioscience

09/03/2022 22:02

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly
adjusted
loss of 61 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 63 cents per share.
    * Revenue fell 22.1% to $152.00 thousand from a year ago; 
analysts expected $97.50 thousand. 
    * Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 61 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Yield10 Bioscience Inc shares had fallen by 12.0% this
quarter.
    * The company reported a quarterly loss of $2.98 million.
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $21.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 9 at 10:02 p.m.  ​All
figures in US dollars unless otherwise stated